# Definium Therapeutics, Inc.: Form 6-K, filed Nov 16, 2021

- Company: [Definium Therapeutics, Inc.](/companies/dftx.md) (CIK 1813814)
- Form: 6-K
- Filed: 2021-11-16
- Accepted by EDGAR: Nov 16, 2021, 08:31 ET
- Period: 2021-11-16
- Accession: 0001104659-21-139699
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1813814/000110465921139699/tm2133108d1_6k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1813814/000110465921139699/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1813814/000110465921139699/tm2133108d1_6k.htm

Filed Nov 16, 2021.
Source: SEC EDGAR, the filing index for accession 0001104659-21-139699. Last ingested by Listed: Nov 14, 2026, 13:59 ET. No prices; not investment advice.
